How can corporate and strategic LPs invest in VC funds?

Why a corporate invests, and what each motivation implies

Six motivations. Most strategic investors carry more than one, and the mix determines what they will ask for.

• Sector visibility. They want to see what is being built, which usually translates into information rights and a wish to be in the room.
• Company access. They want a route to the portfolio, which is the motivation most likely to create tension with your obligations to founders.
• Corporate venture support. The fund complements a direct programme, and the question of who sees a deal first has to be answered before it arises.
• Return. Some corporate treasuries invest for return alone, and the plainest question is whether this one does.
• Geographic or market entry. The fund is a way into a market the corporate wants to understand, which usually implies a longer relationship than a single commitment.
• Internal signalling. The commitment supports a narrative inside the corporate, which is fragile: strategy changes and a commitment made for signalling reasons is the first re-up to disappear.

The forms strategic participation takes

Five, running from the cleanest to the most entangled.

• A fund commitment on standard terms, with no additional rights. The cleanest arrangement and the one to aim for.
• A fund commitment with enhanced information rights, which is the most common ask and the one with the most constraints on what you can actually deliver.
• A fund commitment with co-investment rights, which Blueprint's page on most favoured nation and co-investment rights covers in mechanism and which raises allocation questions immediately. Cooley's published commentary on co-investment vehicles records the typical arrangement it has seen as full carry matching the underlying main fund with either no management fee or a small reduced one, which is the economic shape a strategic investor will usually expect.
• A commitment alongside a commercial relationship between the corporate and the fund's manager, which needs to be documented separately and disclosed.
• A commitment alongside commercial relationships with portfolio companies, which is where the conflict is sharpest and where founders' interests, not the fund's, are the ones most at risk.

Information rights, and the limit that protects everybody

Strategic investors ask for portfolio detail more often than financial investors do, and the constraint on granting it is not negotiating posture but capability.

Cooley's practitioner commentary notes that a manager should preserve confidentiality carve-outs, because a fund may not always be able to provide portfolio company information where doing so would breach confidentiality agreements, securities laws, controls on material non-public information, or portfolio company expectations. That is the answer to give: not that you would rather not, but that you may not, and that the carve-out protects the investor too by keeping them out of information they may not want.

The second limit is competitive. A portfolio company whose competitor sits in your fund and receives detailed reporting has a problem with your fund, and founders talk to each other. What information a strategic investor receives should be a decision you would be comfortable explaining to every founder in the portfolio.

The questions to ask before accepting strategic capital

Ask all of them, in the first substantive conversation, and write the answers down. A strategic investor who finds these questions unreasonable has told you something important.

• What are you actually trying to get from this, beyond the return?
• Who inside your organisation owns this commitment, and what happens to it if that person leaves?
• Is this a single commitment or the start of a programme?
• What information do you expect to receive, and in what form?
• Do you invest directly in companies at our stage, and how would we handle an opportunity we both want?
• Would you want to do commercial business with our portfolio companies, and are you comfortable with us telling founders you are an investor in the fund?
• What would you need us to disclose internally about the portfolio, and to whom does it go?
• Are there sectors or companies you could not be exposed to, which is an excuse-right question in disguise?
• Do you expect any role in governance, and would you want an advisory committee seat?
• What happens to this commitment if your corporate strategy changes?
• Would you be comfortable with your participation being visible to our other investors, and to founders?
• Who signs, and what is your internal approval timeline, which is usually longer than a first-time manager plans for?

What has to be documented, and where

Four places, and the failure mode is agreeing something in conversation that lands in none of them.

• The partnership agreement, which governs everything that applies to all investors, including how conflicts and allocation are handled.
• The side letter, which carries the investor-specific rights and, critically, the obligations that come with them. Blueprint's page on side letters covers the categories and the matrix that tracks them.
• The conflicts register, since a strategic investor is a structural conflict rather than an event. Blueprint's page on conflicts covers the five available responses and why disclosure is only one of them.
• The reporting calendar, so that whatever additional reporting was agreed has an owner and a date rather than an intention.

What other limited partners are testing

The strategic investor is not the only one assessing this arrangement. The rest of your investor base is too.

• Does the strategic investor get anything the others do not, and was that disclosed?
• Is the allocation rule between the fund and the corporate's direct programme written down?
• Are founders aware, and is the manager comfortable that they are?
• Does the information the corporate receives create a competitive problem inside the portfolio?
• Would this commitment survive a change of corporate strategy, and what is the plan if it does not?

What this page does not state

It names no corporate investor, states no ticket size, mandate, or process, and describes no programme, because none of those is published and an invented one would be a fabrication.

It also takes no position on whether to accept strategic capital. For many first funds it is the available capital, and the right answer is to accept it with the expectations documented rather than to decline it on principle.

This page is educational and general. It is not legal advice. What may be granted, what must be disclosed, and how conflicts are handled are governed by your fund documents and should be settled with fund counsel.